Across the Middle East, couples struggle with infertility every year. Ali Hellani, PhD, Founder and Lab Director of Viafet Genomics Center in Dubai, UAE, discusses his passion to help couples undergoing in vitro fertilization (IVF) by providing them with reliable genetic screening technologies. Dr Hellani explains that his lab switched to Illumina next-generation sequencing (NGS) solutions in 2015 because of their accuracy and affordability. Learn how Viafet is now able to positively impact couples in the Middle East and worldwide with Illumina preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) solutions. To learn more about the Illumina PGS solution, visit our website here.
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015.
Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc